複合藥房市場規模、佔有率和成長分析（按治療領域、年齡層、類型、不孕性別和地區）- 行業預測 2025-2032

複合藥局市場規模預計將到 2023 年達到 152 億美元，並從 2024 年的 160.8 億美元成長到 2032 年的 252.5 億美元，預測期內（2025-2032 年）的複合年成長率為 5.8%。

複合藥房市場預計將成長，原因有幾個，包括專利到期的增加、預期壽命的增加以及老年人口的增加。配藥藥房專門製造個人化藥物，滿足患者的特定需求，通常是在非處方藥不可用的情況下。這些藥物可以配製成各種劑型，包括調味液體、乳霜、凝膠和栓劑，由執業醫師開立處方。 2021 年，成年人佔據了 47% 的市場佔有率，配藥藥房也提供營養補充劑以支持日常健康。此外，與不良生活方式相關的慢性病發病率不斷上升，可能會進一步刺激對複合解決方案的需求，從而加速未來幾年的市場擴張。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 客戶和購買標準分析

配藥藥房市場規模（按治療領域和複合年成長率） (2025-2032)

• 市場概況
• 荷爾蒙補充療法
• 疼痛管理
• 專科藥物
• 皮膚科
• 營養補充品
• 其他

配藥藥房市場規模（按年齡層別分類）及複合年成長率（2025-2032 年）

• 市場概況
• 孩子們
• 成人
• 老年人

配藥藥房市場規模（按類型和複合年成長率） (2025-2032)

• 市場概況
• 藥物成分變更 (PIA)
• 目前無法使用的藥品製造 (CUPM)
• 藥物劑量調整 (PDA)
• 其他

配藥藥房市場規模：無菌性和複合年成長率（2025-2032）

• 市場概況
• 已滅菌
• 非無菌

配藥藥房市場規模（按地區分類）及複合年成長率（2025-2032 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• B. Braun Melsungen AG（Germany）
• Fagron NV（Belgium）
• Fresenius Kabi AG（Germany）
• Becton, Dickinson and Company（United States）
• McGuff Compounding Pharmacy Services Inc.（United States）
• Village Compounding Pharmacy（United States）
• Dougherty's Pharmacy, Inc.（United States）
• Institutional Pharmacy Solutions（United States）
• Lorraine's Pharmacy（United States）
• Triangle Compounding Pharmacy（United States）
• Custom Med Apothecary（United States）
• Olympia Pharmacy（United States）
• Precision Compounding Pharmacy（United States）
• College Pharmacy（United States）

結論和建議

Compounding Pharmacy Market size was valued at USD 15.2 billion in 2023 and is poised to grow from USD 16.08 billion in 2024 to USD 25.25 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The Compounding Pharmacy Market is poised for growth driven by several key factors, including a rise in patent expirations, longer life expectancy, and a growing elderly demographic. Compounding pharmacies specialize in creating personalized medications that cater to the specific needs of patients, often when commercial options are unavailable. These medications can be formulated into diverse dosage forms such as flavored liquids, creams, gels, and suppositories, as prescribed by licensed physicians. In 2021, adults constituted 47% of the market share, with compounding pharmacies also offering nutritional supplements to support daily wellness. Furthermore, the increasing prevalence of chronic diseases linked to poor lifestyle choices will further fuel the demand for compounded solutions, accelerating market expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Compounding Pharmacy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Compounding Pharmacy Market Segments Analysis

Global Compounding Pharmacy Market is segmented by Therapeutic Area, Age Cohort, Type, Sterility and region. Based on Therapeutic Area, the market is segmented into Hormone Replacement Therapy, Pain Management, Specialty Drugs, Dermatology, Nutritional Supplements and Others. Based on Age Cohort, the market is segmented into Pediatric, Adult and Geriatric. Based on Type, the market is segmented into Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA) and Others. Based on Sterility, the market is segmented into Sterile and Non-sterile. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Compounding Pharmacy Market

The Compounding Pharmacy market is expected to experience a compound annual growth rate (CAGR) exceeding 6% until 2028, largely fueled by the growing preference for oral pharmaceuticals, such as tablets and capsules. This rise in demand is attributed to the fact that many medical conditions can be most effectively managed through oral administration of medications. As patients increasingly seek convenient and effective treatment options, the reliance on orally delivered pharmaceuticals is set to expand, further propelling growth in the Compounding Pharmacy sector. This trend signifies a notable shift towards customized solutions in the pharmaceutical industry.

Restraints in the Compounding Pharmacy Market

The Compounding Pharmacy market is facing challenges due to an increase in the number of drugs that are prohibited from being compounded in large quantities. For instance, the U.S. FDA announced in June 2015 that it would restrict certain medications, including acetaminophen, aprotinin (Trasylol), ondansetron hydrochloride (Zofran), and bromocriptine mesylate (Tylenol), from being compounded by external institutions. This regulation could lead to a significant decline in demand for commonly compounded pharmaceuticals such as Tylenol, thereby adversely impacting the sales potential of compounded products from complex drug pharmacies. This restraint poses a notable hurdle for market growth and sustainability.

Market Trends of the Compounding Pharmacy Market

The compounding pharmacy market is poised for significant growth, driven by heightened research and development in topical formulations such as gels, creams, and ointments. As pharmaceutical companies prioritize innovative solutions to meet specific patient needs and preferences, the demand for customized medications continues to rise. Factors such as an increasing prevalence of skin-related issues, the rising geriatric population, and a growing emphasis on personalized medicine are further propelling this trend. Consequently, the compounding pharmacy sector is becoming a vital component of the healthcare landscape, paving the way for advanced therapeutic options tailored to individual patient requirements.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer And Buying Criteria Analysis

Global Compounding Pharmacy Market Size by Therapeutic Area & CAGR (2025-2032)

• Market Overview
• Hormone Replacement Therapy
• Pain Management
• Specialty Drugs
• Dermatology
• Nutritional Supplements
• Others

Global Compounding Pharmacy Market Size by Age Cohort & CAGR (2025-2032)

• Market Overview
• Pediatric
• Adult
• Geriatric

Global Compounding Pharmacy Market Size by Type & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Ingredient Alteration (PIA)
• Currently Unavailable Pharmaceutical Manufacturing (CUPM)
• Pharmaceutical Dosage Alteration (PDA)
• Others

Global Compounding Pharmacy Market Size by Sterility & CAGR (2025-2032)

• Market Overview
• Sterile
• Non-sterile

Global Compounding Pharmacy Market Size & CAGR (2025-2032)

• North America (Therapeutic Area, Age Cohort, Type, Sterility)
  • US
  • Canada
• Europe (Therapeutic Area, Age Cohort, Type, Sterility)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Therapeutic Area, Age Cohort, Type, Sterility)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Therapeutic Area, Age Cohort, Type, Sterility)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Therapeutic Area, Age Cohort, Type, Sterility)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fagron NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McGuff Compounding Pharmacy Services Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Village Compounding Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dougherty's Pharmacy, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Institutional Pharmacy Solutions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lorraine's Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Triangle Compounding Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Custom Med Apothecary (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympia Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision Compounding Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• College Pharmacy (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations